Steroids in acute spinal cord injury. An unproven standard of care;Steroidi nel traumatismo midollare. Uno standard di cura non documentato

Minerva Anestesiologica

Volumn 68, Issue 5, 2002, Pages 315-320

  Citerio, G ^a,c   Cormio, M ^a   Sganzerla, E P ^b  

^a Servizio di Anestesia e Rianimazione   (Italy)

^b Clinica Neurochirurgica   (Italy)

^c SAN GERARDO HOSPITAL   (Italy)

Author keywords

Methylprednisolone, therapeutic use; Spinal cord injuries, diagnosis; Spinal cord injuries, therapy

Indexed keywords

METHYLPREDNISOLONE; STEROID; ANTIINFLAMMATORY AGENT;

CONFERENCE PAPER; DISEASE COURSE; HUMAN; PRESCRIPTION; SPINAL CORD INJURY; STANDARDIZATION; STEROID THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ANTI-INFLAMMATORY AGENTS; HUMANS; METHYLPREDNISOLONE; RANDOMIZED CONTROLLED TRIALS; SPINAL CORD INJURIES; STEROIDS;

EID: 0036582345     PISSN: 03759393     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (26)

1. Amar PA, Levy ML. Pathogenesis and pharmacological strategies for mitigating secondary damage in acute spinal cord injury. Neurosurgery 1999;44:1027-40.
2. Bracken MB, Aldrich EF, Herr DL, Hitchon PW, Holford TR, Marshall LF et al. Clinical measurement, statistical analysis, and riskbenefit: Controversies from trials of spinal injury. J Trauma 2000;48:558-61.
3. Bracken MB, Collins WF, Freeman DF, Shepard MJ, Wagner FW, Silten RM et al. Efficacy of methylprednisolone in acute spinal cord injury. JAMA 1984;251:45-52.
4. Bracken MB, Freeman DH, Hellenbrand K. Incidence of acute traumatic spinal cord injury in the United States, 1970-1977. Am J Epidemiol 1981;113:6l5-22.
5. Bracken MB, Holford TR. Effects of timing of methylprednisolone or naloxone administration on recovery of segmental and long tract neurological function in NASCIS 2. J Neurosurg 1993;79:500-7.
6. Bracken MB, Shepard MJ, Collins WF Jr, Holford TR, Baskin DS, Eisenberg HM et al. Methylprednisolone or naloxone treatment after acute spinal cord injury: 1 year follow up data. Results of the Second National Acute Spinal Cord Injury Study. J Neurosurg 1992;76:23-31.
7. Bracken MB, Shepard MJ, Collins WF, Holford TR, Young W, Baskin DS et al. A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal cord injury: Results of the Second National Acute Spinal Cord Injury Study (NASCIS2). N Engl J Med 1990;322:1405-11.
8. Bracken MB, Shepard MJ, Hellenbrand KG, Collins WF, LeoSummers L, Freeman DF et al. Methylprednisolone and neurological function 1 year after spinal cord injury: Results of the National Acute Spinal Cord Injury Study. J Neurosurg 1985;63:704-13.
9. Bracken MB, Shepard MJ, Holford TR, LeoSummers L, Aldrich EF, Fazl M et al. Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury: Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial-National Acute Spinal Cord Injury Study. JAMA 1997;277:1597-604.
10. Bracken MB, Shepard MJ, Holford TR, LeoSummers L, Aldrich EF, Fazl M et al. Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1 year follow-up:Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. J Neurosurg 1998;889:699-706.
11. Bracken MB. Methylprednisolone and acute spinal cord injury: An update of the randomized evidence. Spine 2001;26(24 Suppl):S47-54.
12. Bracken MB. Pharmacological interventions for acute spinal cord injury. Cochrane Database Syst Rev 2001;1:1-32.
13. Garfin SR, Shackford SR, Marshall LF, Drummond JC. Care of the multiply injured patient with cervical spine injury. Clin Orthop 1989;239:19-29.
14. Green BA, David C, Falcone S. Spinal cord injuries in adults. In: Youmans JR, editor. Neurological Surgery. A Comprehensive Reference Guide to the Diagnosis and Management of Neurosurgical Problems. Philadelphia: WB Saunders, 1996:1969-90.
15. Green BA, Klose JK, Goldberg ML. Clinical and research considerations in spinal cord injury. In: Becker DP, editor. Central Nervous System Trauma Status Report. Washington, DC: National Institute of Health, 1985:341-68.
16. Green BA, Magana I. Spinal injury pain. In: Long DM, editor. Current Therapy in Neurologic Surgery. Philadelphia: BC Decker, 1989:294-7.
17. Haclley N. Pharmacological Therapy after Acute Cervical Spinal Cord Injury. Neurosurgery 2002;50(3): S63-73.
18. Hurlbert RJ. Methylprednisolone for acute spinal cord injury: an inappropriate standard of care. J Neurosurg 2000;93:1-7.
19. Hurlbert RJ. The Role of Steroids in Acute Spinal Cord Injury. An Evidence-Based Analysis. Spine 2001;26:S39-46.
20. Nesathurai S. Steroids and spinal cord injury: Revisiting the NASCIS 2 and NASCIS 3 trials. J Trauma 1998;45:1088-93.
21. Pointillart V, Petitjean ME, Wiart L, Vital JM, Lassie P, Thicoipe M et al. Pharmacological therapy of spinal cord injury during the acute phase. Spinal Cord 2000;38:71-6.
22. Short DJ, El Masry WS, Jones PW. High dose methylprednisolone in the management of acute spinal cord injury: A systematic review from a clinical perspective. Spinal Cord 2000;38:273-86.
23. Short DJ. Use of steroids for acute spinal cord injury must be reassessed. BMJ 2000;321:1224.
24. Tator CH, Fehlings MG. Review of the secondary injury theory of acute spinal cord trauma with emphasis on vascular mechanisms. J Neurosurg 1991;75:15-26.
25. Tator CH. Pathophysiology and pathology of spinal cord injury. In: Wilkins RH, Rengachary SS, editors. Neurosurgery. Baltimore: Williams & Wilkins, 1996:2847-59.
26. Tator CH. Review of experimental spinal cord injury with emphasis on the local systemic circulatory effects. Neurochirurgie 1991;37:291-302.